AR009374A1 - Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos. - Google Patents
Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos.Info
- Publication number
- AR009374A1 AR009374A1 ARP970104462A ARP970104462A AR009374A1 AR 009374 A1 AR009374 A1 AR 009374A1 AR P970104462 A ARP970104462 A AR P970104462A AR P970104462 A ARP970104462 A AR P970104462A AR 009374 A1 AR009374 A1 AR 009374A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- hydrogen
- physiologically acceptable
- manufacture
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 239000003703 n methyl dextro aspartic acid receptor blocking agent Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 5
- 239000001257 hydrogen Substances 0.000 abstract 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 5
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 210000005013 brain tissue Anatomy 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002218 hypoglycaemic effect Effects 0.000 abstract 1
- 230000001146 hypoxic effect Effects 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen compuestos de formula (1) donde: X se elige del grupo formado por hidroxi, un éster fisiologicamente aceptable y una amida fisiologicamenteaceptable; Y se elige del grupo formado por hidroxi, un éster fisiologicamente aceptable, y unaamida fisiologicamente aceptable; R es de 1 a 3 sustituyenteselegidos independientemente del grupo formado por hidrogeno, alquilo C1-C4, alcoxi C1-C4, halogeno, -CF3, y -OCF3; R1 se elige del grupo formado porhidrogeno y alquilo C1-C4; R2 es un radical elegido del grupo formado por la formula (2) donde: R3 se elige del grupo formado por hidrogeno y alquilo C1-C4;R4 es de 1 a 2 sustituyentes elegidos independientemente del grupo formado por hidrogeno, alquilo C1-C4, halogeno, y -CF3, R5 es alquilo C1-C4; R6 es alquiloC1-C4; R7 es de 1 a 2 sustituyentes elegidos independientemente del grupo formado por hidrogeno, alquilo C1-C4, alcoxi C1-C4, halogeno y -CF3; y lassales de adicion de ácido farmacéuticamente aceptables del mismo.También se describe una composicion farmacéutica que incluye dicho compuesto y los usos dedichos compuestos para la fabricacion de medicamentos para el tratamiento de enfermedades neurovegetativas, para prevenir el deterioro isquémico/hipoxico/hipoglicémico del tejido cerebral para el tratamiento de la ansiedad y los con efecto analgésico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72317596A | 1996-09-30 | 1996-09-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009374A1 true AR009374A1 (es) | 2000-04-12 |
Family
ID=24905175
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104462A AR009374A1 (es) | 1996-09-30 | 1997-09-29 | Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos. |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0929521B1 (es) |
| JP (1) | JP2001501221A (es) |
| KR (1) | KR20000048715A (es) |
| CN (1) | CN1139572C (es) |
| AR (1) | AR009374A1 (es) |
| AT (1) | ATE309215T1 (es) |
| AU (1) | AU732997B2 (es) |
| BR (1) | BR9712144A (es) |
| CA (1) | CA2266556C (es) |
| DE (1) | DE69734594T2 (es) |
| DK (1) | DK0929521T3 (es) |
| HU (1) | HUP0000882A3 (es) |
| IL (1) | IL129187A0 (es) |
| NO (1) | NO314080B1 (es) |
| NZ (1) | NZ334343A (es) |
| TW (1) | TW492958B (es) |
| WO (1) | WO1998014427A1 (es) |
| ZA (1) | ZA978602B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010053849A1 (en) * | 1999-06-16 | 2001-12-20 | Mary Jeanne Kreek | Plural biological sample arrays, and preparation and uses thereof |
| WO2001082914A2 (en) | 2000-04-28 | 2001-11-08 | Memorial Sloan-Kettering Cancer Center | Topical anesthetic/opioid formulations and uses thereof |
| HU227197B1 (en) | 2000-10-24 | 2010-10-28 | Richter Gedeon Nyrt | Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them |
| US7820688B2 (en) | 2001-04-27 | 2010-10-26 | Memorial Sloan-Kettering Cancer Center | Topical anesthetic/opioid formulations and uses thereof |
| US20030162825A1 (en) * | 2001-11-09 | 2003-08-28 | Sepracor Inc. | D-amino acid oxidase inhibitors for learning and memory |
| DE10306202A1 (de) | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
| BRPI0817860A2 (pt) * | 2007-10-22 | 2019-09-24 | Orchid Res Laboratories Limited | inibidores de histona deacetilase |
| WO2011101774A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
| CA3146163A1 (en) | 2019-07-08 | 2021-01-14 | University Of Health Sciences & Pharmacy In St. Louis | G-protein biased opioid receptor agonist/analgesics with reduced arrestin recruitment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992001670A1 (en) * | 1990-07-16 | 1992-02-06 | Merrell Dow Pharmaceuticals Inc. | Excitatory amino acid antagonists |
| GB9208492D0 (en) * | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
| WO1994027964A1 (en) * | 1993-05-27 | 1994-12-08 | Merrell Dow Pharmaceuticals Inc. | 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists |
| US5519048A (en) * | 1993-05-27 | 1996-05-21 | Merrell Pharmaceuticals Inc. | 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof |
| GB9319243D0 (en) * | 1993-09-17 | 1993-11-03 | Glaxo Spa | Heterocyclic compounds |
-
1997
- 1997-08-18 BR BR9712144-4A patent/BR9712144A/pt not_active IP Right Cessation
- 1997-08-18 DE DE69734594T patent/DE69734594T2/de not_active Expired - Fee Related
- 1997-08-18 IL IL12918797A patent/IL129187A0/xx not_active IP Right Cessation
- 1997-08-18 HU HU0000882A patent/HUP0000882A3/hu unknown
- 1997-08-18 JP JP10516523A patent/JP2001501221A/ja not_active Ceased
- 1997-08-18 CN CNB97198400XA patent/CN1139572C/zh not_active Expired - Fee Related
- 1997-08-18 AT AT97938377T patent/ATE309215T1/de not_active IP Right Cessation
- 1997-08-18 KR KR1019990702680A patent/KR20000048715A/ko not_active Ceased
- 1997-08-18 DK DK97938377T patent/DK0929521T3/da active
- 1997-08-18 CA CA002266556A patent/CA2266556C/en not_active Expired - Fee Related
- 1997-08-18 NZ NZ334343A patent/NZ334343A/xx unknown
- 1997-08-18 WO PCT/US1997/014486 patent/WO1998014427A1/en not_active Ceased
- 1997-08-18 EP EP97938377A patent/EP0929521B1/en not_active Expired - Lifetime
- 1997-08-18 AU AU40718/97A patent/AU732997B2/en not_active Ceased
- 1997-09-24 TW TW086113932A patent/TW492958B/zh not_active IP Right Cessation
- 1997-09-25 ZA ZA9708602A patent/ZA978602B/xx unknown
- 1997-09-29 AR ARP970104462A patent/AR009374A1/es unknown
-
1999
- 1999-03-29 NO NO19991533A patent/NO314080B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0000882A2 (hu) | 2000-09-28 |
| NZ334343A (en) | 2001-01-26 |
| KR20000048715A (ko) | 2000-07-25 |
| ZA978602B (en) | 1998-03-30 |
| HUP0000882A3 (en) | 2001-04-28 |
| JP2001501221A (ja) | 2001-01-30 |
| EP0929521A1 (en) | 1999-07-21 |
| CN1232452A (zh) | 1999-10-20 |
| DE69734594D1 (en) | 2005-12-15 |
| AU4071897A (en) | 1998-04-24 |
| CN1139572C (zh) | 2004-02-25 |
| CA2266556A1 (en) | 1998-04-09 |
| DE69734594T2 (de) | 2006-07-06 |
| IL129187A0 (en) | 2000-02-17 |
| NO991533D0 (no) | 1999-03-29 |
| EP0929521B1 (en) | 2005-11-09 |
| TW492958B (en) | 2002-07-01 |
| CA2266556C (en) | 2007-11-06 |
| AU732997B2 (en) | 2001-05-03 |
| BR9712144A (pt) | 1999-08-31 |
| NO991533L (no) | 1999-05-28 |
| WO1998014427A1 (en) | 1998-04-09 |
| NO314080B1 (no) | 2003-01-27 |
| DK0929521T3 (da) | 2006-03-27 |
| ATE309215T1 (de) | 2005-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO153220C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater. | |
| AR020727A1 (es) | Uso de compuestos derivados 3-amino-4-aril-maleimidas para la preparacion de medicamentos para condiciones asociadas a una necesidad de inhibicion de lagsk-3, dichos compuestos, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden | |
| AR031680A1 (es) | Utilizacion de acrilamidas de quinuclidina para la preparacion de medicamentos, compuestos y composicion farmaceutica | |
| PE20020721A1 (es) | Derivados de quinuclidina como agentes antimuscarinicos m3 | |
| NO873071D0 (no) | Fremgangsmaate for fremstilling av amid-derivater. | |
| NO166126C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
| AR009374A1 (es) | Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos. | |
| MY113062A (en) | Amide derivatives and their therapeutic use | |
| SE8700714D0 (sv) | Anvendning av substituerade 4-fenyl-4-oxo-2-butensyraderivat for framstellning av lekemedel for behandling av sjukdomar i matsmeltningskanalen och som antiulcerost lekemedel | |
| FI923759A0 (fi) | Terapeutiska bensazapinfoereningar. | |
| NO163409C (no) | Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive nitrosoureaderivater. | |
| NO155135C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-amino-1-benzoxepinderivater. | |
| US2316051A (en) | Antispasmodic agents | |
| SE9900190D0 (sv) | New compounds | |
| KR950704236A (ko) | 신규한 페닐에틸 및 페닐프로필아민(Novel Phenylethyl and Phenylpropylamines) | |
| IT1313583B1 (it) | Derivati 2-amminotetralinici per la terapia del glaucoma. | |
| NO164024C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive enantiomerer av substituerte fenylazacykloalkaner. | |
| EP1142575A4 (en) | MEDICINAL PRODUCTS FOR DRY SKIN | |
| ATE83484T1 (de) | 20,21-dinoreburnamenin-derivate, substituiert in position 15 durch eine aminogruppe und deren salze, verfahren zu deren herstellung und die auf diese weise erhaltenen zwischenverbindungen, deren anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen. | |
| KR930701997A (ko) | 항우울제로서의 1-치환된 페녹사티인 유도체 | |
| AR012296A1 (es) | Un compuesto derivado de la fenoximetil piperidina, su uso, un procedimiento para su preparacion y un medicamento que contiene uno o mascompuestos derivados de la fenoximetil piperidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |